TRADE NEWS: Agilent Technologies Launches Innovative Cloning Kit
18 Febrero 2015 - 10:00AM
Business Wire
Agilent Technologies Inc. (NYSE:A) today introduced SureVector,
the world’s first modular vector kit for researchers involved in
molecular cloning and DNA assembly.
Since acquiring Stratagene in 2007, Agilent has been a leading
provider of molecular biology tools and is one of the few companies
that offer a set of products that address the entire workflow for
molecular and synthetic biology.
Harnessing the efficiency of next-generation DNA assembly
technologies, SureVector provides a synthetic biology-based
approach to creating vectors from small fragments of DNA that
include the features to make these vectors functional in a variety
of cell types.
“SureVector enables biologists to quickly, efficiently and
reliably construct customized vectors [small DNA molecules within
cells that can replicate independently] from standard components,”
said Jacob Thaysen, president of Agilent’s Diagnostics and Genomics
Group. “It will change the way people think about and do molecular
cloning.”
Laboratories that rely on service providers to create custom
vectors often pay high per-unit costs and must endure long lead
times. The alternative, ordering DNA fragments and assembly enzymes
separately, leaves the lab to toil with DNA/enzyme combinations
that have not been validated and may require extensive
troubleshooting.
With SureVector, on the other hand, Agilent provides an
extensively validated set of standardized parts that can be
assembled into thousands of combinations covering a huge portion of
commercially available vectors.
“As a result, labs will be able to design, create and use a new
custom vector in less than a day, rather than the two weeks it
often takes today,” Thaysen said. “What’s more, SureVector offers
extraordinary flexibility at less than a third of the average
per-unit price of custom vectors.”
This new product is part of Agilent’s cutting-edge synthetic
biology product line, which includes both the highest-fidelity DNA
synthesis platform and advanced measurement instruments such as
mass spectrometry systems. SureVector follows QuikChange HT and the
SureGuide CRISPR/Cas system as the latest in a series of
next-generation tools for the molecular and synthetic biology
community.
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A), a global leader in life
sciences, diagnostics, and applied chemical markets, is the premier
laboratory partner for a better world. Agilent works with customers
in more than 100 countries, providing instruments, software,
services, and consumables for the entire laboratory workflow.
Agilent generated revenues of $4.0 billion in fiscal 2014. The
company employs about 12,000 people worldwide. Information about
Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
EDITORIAL CONTACT:for Agilent Technologies Inc.Jennifer Mann,
+1-303-357-2391jmann@webershandwick.com
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024